Trial: 202105015

An Open-Label Multicenter Phase Ib Study of AN0025 in Combination with Pembrolizumab in Patients with Advanced Solid Tumors

Phase

I (Cancer Control)

Principal Investigator

Park, Haeseong

Disease Site

Breast; Cervix; Colon; Lung; Lung Cancer – Non-small Cell; Rectum; Urinary Bladder

Learn more about this study at: clinicaltrials.gov